Results 51 to 60 of about 76,872 (109)

Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021. [PDF]

Infect Drug Resist, 2023
Su Y, Qi M, Zhong M, Yu N, Chen C, Ye Z, Cheng C, Hu Z, Zhang H, Wei H.   +9 more
europepmc   +1 more source

Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance. [PDF]

AIDS Res Ther, 2023
Rhee SY, Schapiro JM, Saladini F, Zazzi M, Khoo S, Shafer RW.   +5 more
europepmc   +1 more source

Changes in HIV-1 Subtypes/Sub-Subtypes, and Transmitted Drug Resistance Among ART-Naïve HIV-Infected Individuals - China, 2004-2022. [PDF]

China CDC Wkly, 2023
Liu X, Wang D, Hu J, Song C, Liao L, Feng Y, Li D, Xing H, Ruan Y.   +8 more
europepmc   +1 more source

The Epidemiology of HIV‐1 Resistance to Two‐Drug Regimens in Multicenter Cohort From Poland—A Cross‐Sectional Study

Health Science Reports
Background and Aims Concerns about antiretroviral therapy failure are growing among people with HIV receiving two‐drug regimens, as these schemes include fewer active agents, while the prevalence of transmitted resistance in HIV‐1 continues to increase ...
Andrzej Załęski, Agnieszka Lembas, Joanna Osińska, Tomasz Dyda, Magdalena Suchacz, Justyna Stempkowska‐Rejek, Justyna Orzechowska, Alicja Wiercińska‐Drapało   +7 more
doaj   +1 more source

Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018. [PDF]

Clin Infect Dis, 2022
McClung RP, Oster AM, Ocfemia MCB, Saduvala N, Heneine W, Johnson JA, Hernandez AL.   +6 more
europepmc   +1 more source

Characterization of HIV-1 molecular epidemiology and transmitted drug-resistance in newly diagnosed HIV-infected patients in Sichuan, China. [PDF]

BMC Infect Dis, 2022
Zhou C, Liang S, Li Y, Zhang Y, Li L, Ye L, Yuan D, Su L.   +7 more
europepmc   +1 more source

Prevalence of transmitted drug resistance mutations among patients infected with human immunodeficiency virus type 1 (HIV-1) in Henan Province, China. [PDF]

Chin Med J (Engl), 2022
Liu J, Zhang X, Hou M, Wei S, Ma J, Xu L, Yang X, Sun Y, Liu C, Zhao Q, Huo Y.   +10 more
europepmc   +1 more source

HIV-1-Transmitted Drug Resistance and Transmission Clusters in Newly Diagnosed Patients in Portugal Between 2014 and 2019. [PDF]

Front Microbiol, 2022
Pingarilho M, Pimentel V, Miranda MNS, Silva AR, Diniz A, Ascenção BB, Piñeiro C, Koch C, Rodrigues C, Caldas C, Morais C, Faria D, da Silva EG, Teófilo E, Monteiro F, Roxo F, Maltez F, Rodrigues F, Gaião G, Ramos H, Costa I, Germano I, Simões J, Oliveira J, Ferreira J, Poças J, da Cunha JS, Soares J, Henriques J, Mansinho K, Pedro L, Aleixo MJ, Gonçalves MJ, Manata MJ, Mouro M, Serrado M, Caixeiro M, Marques N, Costa O, Pacheco P, Proença P, Rodrigues P, Pinho R, Tavares R, de Abreu RC, Côrte-Real R, Serrão R, Castro RSE, Nunes S, Faria T, Baptista T, Martins MRO, Gomes P, Mendão L, Simões D, Abecasis A.   +55 more
europepmc   +1 more source

Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection. [PDF]

J Acquir Immune Defic Syndr, 2021
Muccini C, Pinyakorn S, Sirivichayakul S, Kroon E, Sacdalan C, Crowell TA, Trichavaroj R, Ananworanich J, Vasan S, Phanuphak N, Colby DJ, RV254 Study Group.   +11 more
europepmc   +1 more source

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance. [PDF]

Viruses, 2021
Rhee SY, Tzou PL, Shafer RW.
europepmc   +1 more source